Peru Establecimiento Farmaceutico: Sanitary Operating Authorization Guide

Regulatory information verified as of October 29, 2026

1. Key takeaways

The sanitary operating authorization (Autorización Sanitaria de Funcionamiento) is a precondition for a pharmaceutical establishment (Establecimiento Farmacéutico) in Peru to commence operations: without the authorization the establishment may not operate, and after obtaining it the facility remains subject to supervisory inspections that may occur without prior notice. The authorization is based on D.S. N° 014-2011-SA (Reglamento de Establecimientos Farmacéuticos, published on 2011-07-27), as amended by R.M. N° 966-2019/MINSA (published on 2019-10-16) through a ministerial resolution. The article numbers governing the validity period and renewal rules of the authorization are pending verification, and the official publication governs. In project terms, this authorization is the foundation layer of a Peru market entry: it exists before any sanitary registration and it determines whether an obtained registration can be maintained over its full life. It also frames the division of responsibilities within the holding structure: the authorization belongs to the establishment, the registration belongs to the product, and every downstream obligation, from inspections to record keeping, is anchored at the authorized facility rather than at the foreign manufacturer.

GRZAN treats this authorization as the foundational proof of a holding entity’s capability, because it precedes the sanitary registration in time and determines whether the registration can be executed stably afterwards.

2. Legal basis

Regulatory information verified as of October 29, 2026.

3. Expert insights

Insight one: the pre-authorization inspection verifies static conditions, while unannounced post-authorization inspections verify dynamic maintenance. These are two distinct verification mechanisms. The former checks, at the application stage, whether the facility layout, installations and equipment, staffing, and the qualification of the technical director (Director Técnico) meet the requirements of D.S. N° 014-2011-SA. The latter verifies, during operation, that these conditions continue to hold. The key mechanical point is that the authorization is not a one-time conclusive judgment but an administrative confirmation of a continuing state of conformity, which is why material changes in facility conditions trigger reassessment.

Insight two: the amendment was made by ministerial resolution, which shows that this regulation is in a state of frequent adjustment. R.M. N° 966-2019/MINSA amended a supreme decree level instrument, D.S. N° 014-2011-SA, through a Resolución Ministerial, reflecting Peru’s two-layer structure for establishment regulation: a framework decree plus technical amendments. The practical implication for holding entities is that compliance understanding based only on the 2011 version is insufficient; ongoing alignment with the amended technical requirements is necessary, especially for storage, cold chain, and documentation retention requirements.

Insight three: the authorization and the sanitary registration are sequential, not parallel. A pharmaceutical establishment must first obtain the sanitary operating authorization before it can act as a qualified entity to apply for or receive the transfer of a sanitary registration (Registro Sanitario, RS). This sequential chain determines project scheduling: the path of building a proprietary holding entity carries one more upstream step than engaging an existing entity, and that step includes an on-site inspection. A completed document package cannot substitute for a passed inspection.

Insight four: good storage practice is the substantive lever of inspections. The BPA manual of R.M. N° 132-2015/MINSA (2015-03-02) covers laboratories, Droguerías (wholesale distributors), specialized warehouses, and customs warehouses, and is relevant to cold chain devices. At the substantive level, unannounced inspections most easily land on storage conditions, temperature records, and traceability documentation, and these three items are precisely what foreign manufacturers find hardest to control remotely. The enforceability of a sanitary registration with a 5-year validity obtained and maintained under D.S. N° 016-2011-SA (published on 2011-07-27) is in practice constrained by whether the establishment can pass such inspections. In this sense the authorization layer and the registration layer are not merely sequential in time; they remain coupled in risk, because a facility-level finding during an unannounced inspection can degrade the practical usability of every registration parked at that facility.

4. Practical recommendations

1. When building a proprietary holding entity, place the upstream inspection for the sanitary operating authorization on the critical path and reserve time for on-site remediation.
2. When engaging an existing entity, obtain the authorization document and verify its facility address, business scope, and current status.
3. Establish and retain temperature records, incoming goods acceptance, and traceability documentation in accordance with R.M. N° 132-2015/MINSA, so they can be produced at any time during unannounced inspections.
4. Track amendments after R.M. N° 966-2019/MINSA; the validity period and renewal rules of the authorization are governed by the official publication.
5. Before material changes in facility conditions (relocation, expansion, replacement of storage installations), assess in advance whether the change triggers a reassessment obligation.
6. Agree with the technical director (Director Técnico) on the division of duties for accompanying inspections and on-site evidence handling.

5. Verification checklist

□ The sanitary operating authorization document has been obtained and checked, confirming it is based on D.S. N° 014-2011-SA.

□ The current establishment requirements after the R.M. N° 966-2019/MINSA amendment have been checked.

□ Storage and cold chain records have been established under R.M. N° 132-2015/MINSA and can be produced on demand.

□ The facility address and business scope have been confirmed as consistent with actual operations.

□ The validity period and renewal rules of the authorization have been marked as governed by the official publication.

□ The technical director has been assigned responsibility for accompanying unannounced inspections.

□ Regulatory information verified as of October 29, 2026.

Regulatory information verified as of October 29, 2026.

GRZAN provides medical device registration support in Peru for manufacturers, importers, and authorized representatives. For inquiries, contact info@grzanglobal.com.

*GRZAN Regulatory Affairs Team*